The State of Immune Checkpoint Modulators: Today and Tomorrow
The cancer immunotherapy market is projected to reach close to $125 billion worldwide by 2024, rising from $37.5 billion in 2015.
This new trends report features data and insights from Pharma Playbook to explore the current and future state of Immune Checkpoint Modulators (ICM).
Using Signals Analytics’ Pharma Playbook configurable data and analytics platform, this report will give you powerful insights into this and more:
The Origin & Leading Players of ICM
Research & Development Activity Surrounding ICM
ICM Use Cases in Oncology
Potential of ICM Beyond Cancer